Cisatracurium Besylate

Product NDC: 25021-669
11-digit product format: 250210669
Labeler code: 25021
Product ID: 25021-669_507a0145-c6e8-4dcc-8199-3d0674517939
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: cisatracurium besylate
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Labeler: Sagent Pharmaceuticals
Application: ANDA201836
Marketing category: ANDA
Marketing start: 2021-11-01
Marketing end: 0000-00-00
Substance: CISATRACURIUM BESYLATE
Active strength: 10 mg/mL
Pharmacologic classes: Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
25021-669-20	2021-01-20	C162847	48780-1	9d75b9d0-d522-f424-e053-dadaa90a57ce	557d1d6b-9010-492f-b2d3-9558fbb56d01
25021-669-20	2020-01-31	C162847	48780-1	9d75b9d0-d522-f424-e053-dadaa90a57ce	557d1d6b-9010-492f-b2d3-9558fbb56d01

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
25021-669-20	ML - Milliliter	25021-669	ad01ee18-b42e-482e-b055-7c09d4ffc268	1	2014-12-01

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
80YS8O1MBS	CISATRACURIUM BESYLATE	96946-42-8	CISATRACURIUM BESYLATE

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
25021-669-20	25021066920	1 VIAL in 1 CARTON (25021-669-20) > 20 mL in 1 VIAL	1 vial	2021-11-01	0000-00-00	No	No	Current